Therapeutic Use of Stem Cells for Myocardial Infarction
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality worldwide, with acute myocardial infarction (AMI) representing the most common CVD. Coronary artery
disease (CAD) resulting in myocardial infarction (MI) can lead to ischemic heart damage, which, depending on the ability and timing of reperfusion, may be reversible or irreversible. Cardiomyocytes depend on constant delivery of oxygen and nutrients due to the heart’s limited capacity for anaerobic metabolism.